Cline Darren S Insider Trades

Insider Trading History

Track insider trading activity for Cline Darren S. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $78k 45,867 shares
Last Trade
Mar 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.4k 45,867 shares
$1.36
$1.70
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Chief Commercial Officer
Holding Value $2.14M 40,000 shares
Last Trade
Jan 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.53M 60,000 shares
$42.15
$53.46
Xenon Pharmaceuticals
Xenon Pharmaceuticals XENE
Chief Commercial Officer
Holding Value $9.93M 185,800 shares
Last Trade
Jun 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.85M 185,800 shares
$31.49
$53.46
Pliant Therapeutics
Pliant Therapeutics PLRX
Director
Holding Value $35.4k 30,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.3k 30,000 shares
$1.61
$1.18
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $62.9k 36,979 shares
Last Trade
Mar 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.2k 36,979 shares
$0.98
$1.70
Pliant Therapeutics
Pliant Therapeutics PLRX
Director
Holding Value $31.6k 26,764 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$350k 26,764 shares
$13.06
$1.18
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $427k 251,405 shares
Last Trade
Mar 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$135k 35,219 shares
$3.83
$1.70
Impel Pharmaceuticals
Impel Pharmaceuticals IMPL
Director
Holding Value $529 13,222 shares
Last Trade
Jun 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.7k 13,222 shares
$1.34
$0.04
Pliant Therapeutics
Pliant Therapeutics PLRX
Director
Holding Value $16.5k 14,000 shares
Last Trade
Jun 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$323k 14,000 shares
$23.09
$1.18
Impel Pharmaceuticals
Impel Pharmaceuticals IMPL
Director
Holding Value $801 20,013 shares
Last Trade
Apr 12, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.4k 20,013 shares
$1.42
$0.04
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $368k 216,186 shares
Last Trade
Mar 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$308k 139,355 shares
$2.21
$1.70
Pliant Therapeutics
Pliant Therapeutics PLRX
Director
Holding Value $26k 22,000 shares
Last Trade
Mar 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$684k 22,000 shares
$31.11
$1.18
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $131k 76,831 shares
Last Trade
Mar 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$270k 66,831 shares
$4.04
$1.70
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $17k 10,000 shares
Last Trade
Dec 08, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$93.9k 10,000 shares
$9.39
$1.70
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $0 0 shares
Last Trade
Oct 07, 2021 Sale
No data
No data
$1.70
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $71.7k 42,191 shares
Last Trade
Oct 07, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.70
GW Pharmaceuticals
GW Pharmaceuticals GWPH
U.s. Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
May 05, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$13.1M 59,748 shares
$218.96
$218.96
GW Pharmaceuticals
GW Pharmaceuticals GWPH
U.s. Chief Commercial Officer
Holding Value $38.8M 177,180 shares
Last Trade
Jun 04, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.1M 283,500 shares
$127.34
$218.96
GW Pharmaceuticals
GW Pharmaceuticals GWPH
U.s. Chief Commercial Officer
Holding Value $1.61M 7,356 shares
Last Trade
May 28, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$923k 7,356 shares
$125.46
$218.96
GW Pharmaceuticals
GW Pharmaceuticals GWPH
U.s. Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
May 28, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$923k 7,356 shares
$125.46
$218.96

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up